201 Carboplatin, paclitaxel and pembrolizumab for the first line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma

• Alain Algazi,
• Hyunseok Kang,
• Angelica Valadez,
• Madeleine Welsh,
• Christine Kim,
• Angela Johns

Affiliations

Alain Algazi

University of California, San Francisco, San Francisco, CA, USA

Hyunseok Kang

University of California, San Francisco, San Francisco, CA, USA

Angelica Valadez

University of California, San Francisco, San Francisco, CA, USA

Madeleine Welsh

University of California, San Francisco, San Francisco, CA, USA

Christine Kim

University of California, San Francisco, San Francisco, CA, USA

Angela Johns

University of California, San Francisco, San Francisco, CA, USA